We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+1.52%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$486B
AUM Growth
+$2.12B
Cap. Flow
+$867M
Cap. Flow %
0.18%
Top 10 Hldgs %
13.96%
Holding
2,615
New
76
Increased
1,051
Reduced
777
Closed
79

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.76B
2
CI icon
Cigna
CI
+$1.44B
3
BMY icon
Bristol-Myers Squibb
BMY
+$1.26B
4
OXY icon
Occidental Petroleum
OXY
+$763M
5
DHR icon
Danaher
DHR
+$762M

Sector Composition

Rank Sector Weight
1 Healthcare 22.87%
2 Financials 13.64%
3 Consumer Discretionary 13.54%
4 Industrials 10.67%
5 Technology 10.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KND
1976
DELISTED
Kindred Healthcare
KND
$510K ﹤0.01%
25,153
UMBF icon
1977
UMB Financial
UMBF
$11.4B
$508K ﹤0.01%
8,908
HT
1978
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
$508K ﹤0.01%
19,800
CATY icon
1979
Cathay General Bancorp
CATY
$4.3B
$505K ﹤0.01%
15,556
LTC
1980
LTC Properties
LTC
$2.09B
$505K ﹤0.01%
12,150
PMT
1981
PennyMac Mortgage Investment
PMT
$827M
$505K ﹤0.01%
29,000
MBFI
1982
DELISTED
MB Financial Corp
MBFI
$505K ﹤0.01%
14,667
CVBF icon
1983
CVB Financial
CVBF
$4.05B
$504K ﹤0.01%
28,645
+12,500
+77% +$206K
KFY icon
1984
Korn Ferry
KFY
$4.28B
$504K ﹤0.01%
14,500
-400
-3% -$13.2K
RGC
1985
DELISTED
Regal Entertainment Group
RGC
$502K ﹤0.01%
23,990
+4,800
+25% +$103K
VNM icon
1986
VanEck Vietnam ETF
VNM
$514M
$500K ﹤0.01%
26,800
NGG icon
1987
National Grid
NGG
$81.1B
$499K ﹤0.01%
8,012
+134
+2% +$8.77K
OTTR icon
1988
Otter Tail
OTTR
$3.87B
$499K ﹤0.01%
18,750
GOOD
1989
Gladstone Commercial Corp
GOOD
$630M
$498K ﹤0.01%
30,100
-3,000
-9% -$53.3K
SNCR
1990
DELISTED
Synchronoss Technologies
SNCR
$498K ﹤0.01%
1,211
IBOC icon
1991
International Bancshares
IBOC
$4.52B
$497K ﹤0.01%
18,514
-2,700
-13% -$71.7K
NWN icon
1992
Northwest Natural Holdings
NWN
$2.12B
$497K ﹤0.01%
11,790
RNST icon
1993
Renasant Corp
RNST
$3.96B
$496K ﹤0.01%
15,227
+2,500
+20% +$76.3K
KTOS icon
1994
Kratos Defense & Security Solutions
KTOS
$12B
$494K ﹤0.01%
78,357
ACH
1995
Accendra Health
ACH
$93.1M
$493K ﹤0.01%
14,500
NHI icon
1996
National Health Investors
NHI
$3.47B
$492K ﹤0.01%
7,890
CYS
1997
DELISTED
CYS Investments Inc.
CYS
$492K ﹤0.01%
63,691
+4
+0% +$35
KALU icon
1998
Kaiser Aluminum
KALU
$3.1B
$490K ﹤0.01%
5,900
ABM icon
1999
ABM Industries
ABM
$2.84B
$488K ﹤0.01%
14,850
TDW icon
2000
Tidewater
TDW
$4.56B
$484K ﹤0.01%
659
-84
-11% -$68.3K

Similar funds

T. Rowe Price Associates's Q2 2015 Portfolio in Review

As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
  • T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
  • T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
  • T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
  • T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
  • T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
  • T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.

Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.